Glenmark to Sell 7.84% of Life Sciences Unit
On July 10, Glenmark Pharma announced that its board approved selling 7.84% of its shares in Glenmark Life Sciences. The board agreed to sell up to 96,09,571 shares through the stock exchange. Glenmark Pharma shared this news in a filing. On the same day, Glenmark Life Sciences’ shares closed 1.2% lower at Rs 878 each […]
Glenmark to Sell 7.84% of Life Sciences Unit Read More »